Artisan Partners’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-426,285
| Closed | -$73.4M | – | 359 |
|
|
2021
Q3 | $73.4M | Sell |
426,285
-525,825
| -55% | -$68.8M | 0.09% | 212 |
|
|
2021
Q2 | $119M | Sell |
952,110
-26,196
| -3% | -$3.3M | 0.14% | 159 |
|
|
2021
Q1 | $133M | Sell |
978,306
-215,651
| -18% | -$27.9M | 0.17% | 145 |
|
|
2020
Q4 | $153M | Buy |
1,193,957
+13,790
| +1% | +$1.62M | 0.19% | 136 |
|
|
2020
Q3 | $133M | Buy |
1,180,167
+411,822
| +54% | +$41M | 0.19% | 125 |
|
|
2020
Q2 | $73.2M | Buy |
768,345
+258,895
| +51% | +$25M | 0.12% | 167 |
|
|
2020
Q1 | $45.8M | Sell |
509,450
-282,289
| -36% | -$21.9M | 0.1% | 187 |
|
|
2019
Q4 | $42M | Buy |
791,739
+43,093
| +6% | +$1.96M | 0.07% | 202 |
|
|
2019
Q3 | $29.6M | Buy |
748,646
+93,928
| +14% | +$4.07M | 0.06% | 214 |
|
|
2019
Q2 | $26.9M | Buy |
654,718
+62,800
| +11% | +$2.6M | 0.05% | 220 |
|
|
2019
Q1 | $27.6M | Buy |
591,918
+108,751
| +23% | +$4.77M | 0.05% | 214 |
|
|
2018
Q4 | $21M | Sell |
483,167
-29,244
| -6% | -$1.46M | 0.05% | 214 |
|
|
2018
Q3 | $29.3M | Buy |
512,411
+110,263
| +27% | +$5.42M | 0.06% | 199 |
|
|
2018
Q2 | $19.5M | Buy |
402,148
+49,862
| +14% | +$1.82M | 0.04% | 218 |
|
|
2018
Q1 | $13.8M | Sell |
352,286
-20,152
| -5% | -$857K | 0.03% | 233 |
|
|
2017
Q4 | $15.8M | Buy |
372,438
+52,567
| +16% | +$1.97M | 0.03% | 229 |
|
|
2017
Q3 | $11.9M | Buy |
+319,871
| New | +$11.1M | 0.02% | 235 |
|
Artisan Partners's XLRN Position: Q4 2021 in Review
Artisan Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 426,285 shares — an estimated $73.4M sold.
Artisan Partners first reported a position in XLRN in Q3 2017 and held it in 17 quarters. The position peaked at $153M in Q4 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Artisan Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Artisan Partners sold 426,285 Acceleron Pharma shares in Q4 2021, an estimated $73.4M.
- Artisan Partners first reported a position in Acceleron Pharma in Q3 2017 and held it in 17 quarters.
- Artisan Partners's Acceleron Pharma position peaked at $153M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Artisan Partners's 13F filing for Q4 2021, filed 11 Feb 2022.